PATENT CLAIM ANALYSIS

Application Number: 15923650
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "373000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 8):
The method of  claim 1 , wherein the dexpramipexole or a pharmaceutically acceptable salt thereof is administered in a solid unit dose selected from a tablet or capsule.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 90.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15889714', '14912015', '15675912', '15461131', '15181526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8083040807801669
- 35 USC 102 Novelty (BERT): 0.6476010353064203
- Combined Prediction Score: 0.7922337762327922
- Mean Citation Score: 526.019278
- Max Citation Score: 617.0143400000002
- Similarity Product: 578.9356267860211

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test